Payment overview · 2025
General Payments
$335.13
9 reported records · 5 companies
Healthcare provider profile · identity verified
Christopher Wade Hunt, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BOYNTON BEACH, FL · NPI 1235197666
Verified facts
What the public records show
CMS Open Payments records show Christopher Wade Hunt, M.D. received $335.13 in general payments during 2025 across 9 reported records.
AstraZeneca Pharmaceuticals LP accounted for 38.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $129.00 | 38.5% | 1 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $124.38 | 37.1% | 4 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $45.83 | 13.7% | 2 | 2025 |
| Eisai Inc. | Unresolved — no canonical attribution shown | $20.53 | 6.1% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $15.39 | 4.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $335.13 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $129.00 | 1 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $124.38 | 4 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $23.32 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $22.51 | 1 | 2025 |
Source payment records
|
|||||
| Leqembi Normalized: leqembi |
Drug | Eisai Inc. | $20.53 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $15.39 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $15.39 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
21 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
25 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1385 | 401 |
| Amlodipine Besylate | Amlodipine Besylate | 925 | 258 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 846 | 267 |
| Levothyroxine Sodium | Levothyroxine Sodium | 842 | 232 |
| Pantoprazole Sodium | Pantoprazole Sodium | 680 | 218 |
| Alprazolam | Alprazolam | 678 | 200 |
| Losartan Potassium | Losartan Potassium | 601 | 180 |
| Metoprolol Succinate | Metoprolol Succinate | 479 | 140 |
| Lisinopril | Lisinopril | 408 | 117 |
| Metformin Hcl | Metformin Hcl | 391 | 114 |
| Omeprazole | Omeprazole | 383 | 126 |
| Simvastatin | Simvastatin | 338 | 104 |
| Hydrochlorothiazide | Hydrochlorothiazide | 327 | 97 |
| Tamsulosin Hcl | Tamsulosin Hcl | 298 | 92 |
| Trazodone Hcl | Trazodone Hcl | 275 | 87 |
| Sertraline Hcl | Sertraline Hcl | 272 | 73 |
| Gabapentin | Gabapentin | 271 | 102 |
| Zolpidem Tartrate | Zolpidem Tartrate | 252 | 96 |
| Escitalopram Oxalate | Escitalopram Oxalate | 243 | 70 |
| Famotidine | Famotidine | 242 | 92 |
| Ezetimibe | Ezetimibe | 236 | 83 |
| Temazepam | Temazepam | 231 | 65 |
| Metoprolol Tartrate | Metoprolol Tartrate | 213 | 57 |
| Azithromycin | Azithromycin | 212 | 186 |
| Lorazepam | Lorazepam | 205 | 57 |
| Clonazepam | Clonazepam | 201 | 56 |
| Methylprednisolone | Methylprednisolone | 195 | 185 |
| Allopurinol | Allopurinol | 190 | 53 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 186 | 80 |
| Valsartan | Valsartan | 181 | 52 |
| Furosemide | Furosemide | 166 | 58 |
| Tramadol Hcl | Tramadol Hcl | 163 | 56 |
| Glimepiride | Glimepiride | 159 | 42 |
| Prednisone | Prednisone | 156 | 121 |
| Meloxicam | Meloxicam | 153 | 54 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 152 | 134 |
| Clopidogrel | Clopidogrel Bisulfate | 152 | 42 |
| Ipratropium Bromide | Ipratropium Bromide | 151 | 75 |
| Carvedilol | Carvedilol | 149 | 48 |
| Eliquis | Apixaban | 148 | 42 |
| Pravastatin Sodium | Pravastatin Sodium | 147 | 42 |
| Montelukast Sodium | Montelukast Sodium | 146 | 43 |
| Fluticasone Propionate | Fluticasone Propionate | 143 | 61 |
| Duloxetine Hcl | Duloxetine Hcl | 141 | 43 |
| Synthroid | Levothyroxine Sodium | 141 | 39 |
| Finasteride | Finasteride | 132 | 44 |
| Ozempic | Semaglutide | 128 | 23 |
| Potassium Chloride | Potassium Chloride | 126 | 42 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 120 | 34 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 112 | 38 |
| Citalopram Hbr | Citalopram Hydrobromide | 110 | 30 |
| Atenolol | Atenolol | 108 | 31 |
| Alendronate Sodium | Alendronate Sodium | 107 | 37 |
| Bupropion Xl | Bupropion Hcl | 106 | 39 |
| Mirtazapine | Mirtazapine | 106 | 32 |
| Mounjaro | Tirzepatide | 105 | 20 |
| Amoxicillin | Amoxicillin | 104 | 91 |
| Tizanidine Hcl | Tizanidine Hcl | 104 | 45 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 102 | 38 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 101 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 94 | 26 |
| Metformin Hcl Er | Metformin Hcl | 91 | 29 |
| Jardiance | Empagliflozin | 89 | 27 |
| Ondansetron Hcl | Ondansetron Hcl | 80 | 29 |
| Paxlovid | Nirmatrelvir/Ritonavir | 80 | 80 |
| Diazepam | Diazepam | 76 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 76 | 24 |
| Meclizine Hcl | Meclizine Hcl | 76 | 42 |
| Xarelto | Rivaroxaban | 76 | 21 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 72 | 25 |
| Propranolol Hcl | Propranolol Hcl | 71 | 19 |
| Pregabalin | Pregabalin | 70 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 68 | 58 |
| Ramipril | Ramipril | 66 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 62 | 18 |
| Spironolactone | Spironolactone | 58 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 56 | 27 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 55 | 49 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 52 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 51 | 15 |
| Celecoxib | Celecoxib | 51 | 17 |
| Valacyclovir | Valacyclovir Hcl | 51 | 30 |
| Mupirocin | Mupirocin | 50 | 43 |
| Paroxetine Hcl | Paroxetine Hcl | 50 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 48 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 48 | 11 |
| Buspirone Hcl | Buspirone Hcl | 46 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 46 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 45 | 15 |
| Glipizide | Glipizide | 42 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 42 | 20 |
| Sumatriptan Succinate | Sumatriptan Succinate | 38 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 34 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 37 | 26 |
| Cefuroxime | Cefuroxime Axetil | 36 | 26 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | 13 |
| Naproxen | Naproxen | 36 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 36 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 36 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 34 | 15 |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 34 | suppressed |
| Cefdinir | Cefdinir | 33 | 30 |
| Irbesartan | Irbesartan | 33 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 32 | suppressed |
| Estradiol | Estradiol | 32 | 14 |
| Olanzapine | Olanzapine | 32 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 31 | 14 |
| Eszopiclone | Eszopiclone | 31 | 15 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 28 |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 30 | suppressed |
| Glipizide Er | Glipizide | 30 | suppressed |
| Lamotrigine | Lamotrigine | 30 | suppressed |
| Memantine Hcl | Memantine Hcl | 30 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 29 | suppressed |
| Nystatin | Nystatin | 29 | 15 |
| Topiramate | Topiramate | 29 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 27 | suppressed |
| Chlorthalidone | Chlorthalidone | 26 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 26 | suppressed |
| Hydrocortisone | Hydrocortisone | 26 | 17 |
| Midodrine Hcl | Midodrine Hcl | 26 | suppressed |
| Telmisartan | Telmisartan | 26 | suppressed |
| Klor-Con M20 | Potassium Chloride | 25 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 25 | 11 |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Ibuprofen | Ibuprofen | 24 | 14 |
| Linzess | Linaclotide | 24 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Cephalexin | Cephalexin | 22 | 12 |
| Lovastatin | Lovastatin | 22 | suppressed |
| Trulicity | Dulaglutide | 22 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 21 | suppressed |
| Baclofen | Baclofen | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 20 | suppressed |
| Nateglinide | Nateglinide | 20 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Vascepa | Icosapent Ethyl | 20 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 19 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 18 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 18 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Zaleplon | Zaleplon | 18 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Jantoven | Warfarin Sodium | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Scopolamine | Scopolamine | 17 | 12 |
| Sucralfate | Sucralfate | 17 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | 11 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 14 | suppressed |
| Sotalol | Sotalol Hcl | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Eplerenone | Eplerenone | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 13 | suppressed |
| Tradjenta | Linagliptin | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Clarithromycin | Clarithromycin | 12 | 12 |
| Lactulose | Lactulose | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Tadalafil | Tadalafil | 12 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Testosterone | Testosterone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $335.13 · 9 records | AstraZeneca Pharmaceuticals LP | AIRSUPRA, Cologuard Collection Kit, Leqembi, OTEZLA, REPATHA, The Cologuard Plus Collection Kit, Veozah | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error